![]() DHMEQ (racemate) structure
|
Common Name | DHMEQ (racemate) | ||
---|---|---|---|---|
CAS Number | 287194-38-1 | Molecular Weight | 261.23014 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C13H11NO5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of DHMEQ (racemate)DHMEQ racemate is a NF-κB inhibitor. DHMEQ racemate is less active than (-)-DHMEQ. |
Name | Cis(+/-)-2-hydroxy-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)benzaMide |
---|---|
Synonym | More Synonyms |
Description | DHMEQ racemate is a NF-κB inhibitor. DHMEQ racemate is less active than (-)-DHMEQ. |
---|---|
Related Catalog | |
Target |
NF-κB |
In Vitro | DHMEQ racemate (DHM3EQ) and (-)-DHMEQ (DHM2EQ) inhibits TNF-a-induced NF-kB activation. (-)-DHMEQ is more potent and less toxic than DHMEQ racemate[1]. |
In Vivo | The antiarthritic effects of (-)-DHMEQ (DHM2EQ) and DHMEQ racemate (DHM3EQ) are examined on type-II collagen-induced arthritis in DBA1/J mice. This animal model is widely used for evaluation of antirheumatic drugs because of its pathological similarities to human rheumatoid arthritis. The arthritis is elicited and scored. (-)-DHMEQ markedly inhibits type-II-collagen-induced arthritis in mice, whereas DHMEQ racemate tends to only slightly inhibit it[1]. |
References |
Molecular Formula | C13H11NO5 |
---|---|
Molecular Weight | 261.23014 |
Storage condition | 2-8℃ |
DHMEQ (racemate) |